FNCH   $1.882  -6.37% Market Closed

Finch Therapeutics Group Inc
Total Cash 16.04M
totalCashPerShare 9.986
EBITDA -19.51M
Total Debt 28.99M
quickRatio 3.594
currentRatio 3.872
Total Revenue 0.00
debtToEquity 203.875
Revenue/Share 0.0
ROA -0.2189
ROE -0.67280996
grossProfits
freeCashflow -15.96M
operatingCashflow -18.05M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 32.22M
forwardPE
floatShares 896.02K
sharesOutstanding 1.61M
sharesShort 19.20K
sharesShortPriorMonth 10.60K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.53%
heldPercentInstitutions 0.05%
Short Ratio help_outline 0.19%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 8.855
Price To Book help_outline 1.36
earningsQuarterlyGrowth
netIncomeToCommon -14.17M
trailingEps -8.80%
forwardEps -20.59%
enterpriseToEbitda -1.65
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2023
institutionsCount 3
lastUpdated Oct. 16, 2024, 11:55 p.m.